by a local inflammatory reaction in and around islets followed by selective destruction of insulin-secreting β cells (1) . The factors leading to the destruction of the islets are still unknown, but it is thought that immune-based mechanisms are responsible for the death of the β-cells (2) . T cells are critical in the pathogenesis of diabetes. Transfer of T cells isolated from diabetic NOD mice into irradiated NOD recipients leads to diabetes (3) . Furthermore, NOD-nu/nu mice, that lack the thymus, do not develop insulitis or diabetes (4) . Other studies support a role for macrophages in induction of diabetes. Depletion of macrophages with clodronate-loaded liposomes leads to disappearance of dendritic cells, macrophages and lymphocytes from the endocrine pancreas of NOD mice and causes a delay in the onset of diabetes (5) . Moreover, macrophage depletion affects development of β cellcytotoxic T cells and prevents autoimmune diabetes (6) .
Several lines of evidence suggest a role for chemokines in the pathogenesis of diabetes. Chemokines are found in freshly isolated islets or are produced by cultured pancreatic beta cells, including CCL5, CXCL9, CXCL10 (7; 8) , and CCL2 (7; 9) . CCL2 expression in the pancreas also parallels disease progression in NOD mice (10; 11) . CCL21 is not expressed by pancreatic islets normally, but it has been observed in the pancreas of NOD mice (12) and may be an important factor contributing to autoimmunity (13) .
Animals lacking the chemokine receptor for CXCL10, CXCR3, show delayed onset of diabetes subsequent to a viral infection (7) . Also, antibody neutralization of the macrophage-derived chemokine CCL22 causes a significant reduction of CCR4-positive T cells within the pancreatic infiltrates and attenuates disease onset and insulitis frequency in an adoptive transfer model (14) . In addition to a role in recruitment of pathogenic T cells (14; 15) Here we show that several chemokines are expressed before development of diabetes and that islet-specific expression of the panchemokine blocker M3 abrogates inflammatory cell infiltration of the islets and completely blocks development of diabetes in NOD mice. 
RESEARCH

Histology.
For immunohistochemical staining, slides were incubated for 1 hr at room temperature with purified primary antibodies followed by incubation with the appropriate labeled secondary antibodies for 30 min. Primary antibodies used were anti-CD45, CD3, CD31, CD11c, B220, CD11b from BD Biosciences Pharmigen (San Diego, CA); F4/80 from Serotec; anti-CCL1, anti-CCL21, anti-CCL2, and rat antiinsulin from R&D Systems (Minneapolis, MN), rabbit anti-CXCL9 (kindly provided by J. Farber, NIH), anti-CCL3, CCL4, CCL11, CCL22 and CXCL10 (provided by S. Kunkel), and guinea pig polyclonal anti-insulin from DAKOCytomation (Carpinteria, CA). Secondary antibodies used were Alexa Fluor 488-and Alexa Fluor 594-goat antirat IgG from Molecular Probes (Eugene, OR), and Cy3-goat antiArmenian hamster, FITC-donkey anti-Guinea Pig IgG and Cy5-goat anti-rat from Jackson ImmunoResearch (West Grove, PA).
To determine the degree of islet infiltration in NOD and NOD-M3 female mice, and in NOD.SCID mice in transfer experiments, groups of mice were analyzed at 10 or 30 wk of age or 9 wk after transfer respectively, assessing at least 80-100 islets per animal. Insulitis was scored as follows: grade 0, no lesions; grade 1, peri-insular leukocytic aggregates, usually periductal infiltrates; grade 2, <25% islet destruction; and grade 3, >25% islet destruction. An insulitis score for each mouse was obtained by dividing the total score for each pancreas by the number of islets examined. Data are presented as mean insulitis score ± SD for the indicated experimental groups. Isolation of pancreatic islets of Langerhans. Islets of Langerhans were isolated as previously described (18) . Briefly, the common bile duct was clamped distal to the pancreatic duct junction at its hepatic insertion. The proximal common bile duct was then cannulated using a 27-gauge needle, and the pancreas was infused by retrograde injection of 2 ml of ice-cold collagenase-V solution ( Differences were considered significant when P < 0.05.
RESULTS
NOD
islets express several chemokines.In NOD mice infiltration of mononuclear cells into pancreatic islets begins as early as 4-6 wks of age, accumulating in the periphery (peri-insulitis) of a few pancreatic islets (19) . The autoimmune destruction of the islets is extensive by 10 wks of age, [8] [9] [10] [11] [12] wks before the onset of overt diabetes (20; 21) . To analyze the expression of chemokines in islets of NOD female mice, we performed immunostaining using antibodies against CXCL9, CXCL10, CCL1, CCL3, CCL4, CCL22 and CCL24, insulin, CD31 and CD45. By 4-6 wks of age (n=5), the islets of Langerhans had a small number of CD45 + cells that localized to the periphery of the islets ( Fig. 1A and B). All chemokines studied were expressed in islets with peri-insulitis. CCL1, CCL3, CCL4, CCL22, CXCL9 and CXCL10 were primarily expressed by infiltrating cells (Fig.  1C, D , E, G, I and J, respectively). CXCL10 was also expressed by β cells (Fig. 1J ), in agreement with a previous study (22) . CCL24 was expressed by infiltrating cells (Fig.  1H ) and by CD31 + endothelial cells in the islets (Online Appendix Fig. 1 [available at http://diabetes.diabetesjournals.org ]). As described before (12), CCL21 was expressed in para-ductal areas and its expression was increased in areas rich in inflammatory cells ( Figure 1F ). Analysis of pancreata of 10-wk-old mice (n=5) showed increased in the expression of all chemokines studied compared to the earlier time points (data not shown). At this point, large infiltrates occupying the whole islet were observed. Some of these aggregates had T and B cells (Fig. 1K ) and peripheral lymph node addressin (PNAd) positive high endothelial vessels that coexpressed CXCL9 (Fig. 1L) Fig. 2A) .
To investigate the effect of M3 expression by β cells on insulitis we examined pancreata from NOD and NOD-M3 female mice at 10 wks of age (n=5 per group). Semiquantitative analysis of islet infiltrates showed that, as expected, most (95%) islets from NOD nondiabetic mice had peri-insulitis and in some cases developed a destructive inflammatory infiltrate ( Fig. 2B and D) , with marked loss of β-cell mass. In contrast, islets from NOD-M3 mice were virtually devoid of infiltrating cells and showed a normal complement of insulin producing cells (Fig. 2C and D,  P=0.004) . None of the NOD-M3 females that were more than 60 wks of age (n=13) showed insulitis however, only 12±10% of islets had peri-insulitis and in some cases inflammatory cells were present in the exocrine tissue (Online Appendix Fig. 2 ).
Lymphocytes are also often observed in the salivary and lacrimal glands of NOD mice (23) . We analyzed the presence of infiltrates in salivary and lacrimal glands from NOD and NOD-M3 mice at 10 wks of age and onwards. CD45 + infiltrates were found in salivary glands of both NOD (20/20) (Fig. 3A) . Although autoreactive T cells within NOD splenocytes could also induce diabetes in all NOD-M3.SCID recipient mice (11/11) (Fig. 3A) , the development of diabetes was significantly delayed (P=0.0086). To test if the delay in diabetes development was caused by a reduced influx of the cells into the islets we examined pancreata of the recipients 2 wk after transfer. NOD.SCID recipients had insulitis and peri-insulitis in 75% islets ( Fig.  3B and D) . In contrast, NOD-M3.SCID mice (n=5) had mild infiltrates of leukocytes in ~25% of the islets and a normal complement of insulin-producing cells (Fig. 3C  and D) 3E ). Histological analyses of the pancreata from the recipients showed that 100% the islets of the animals transferred with splenocytes from NOD mice had massive cellular infiltration and few remaining insulin-producing cells (Fig. 3F and  H) . Animals that received NOD-M3 splenocytes had diffuse, low-grade infiltrates of leukocytes in the islets and a normal complement of insulinproducing cells (Fig. 3G and H) . Interestingly, most of the NOD.SCID mice that received NOD-M3 splenocytes had infiltration in the islets, but only in 60% of them. Furthermore, these infiltrates were less severe than those observed in recipients of NOD cells (Fig. 3H) . Lymphocytic infiltrates consisting mainly of CD3 + T cells and B220 + B cells, were present in the salivary glands of NOD.SCID mice transplanted with both splenocytes from NOD and NOD-M3 mice (Online Appendix Fig. 3A and B) Fig. 4A , lower left panel). BDC2.5 cells did not proliferate in cervical lymph nodes from NOD and NOD-M3 recipients (Fig. 4A, upper panel) .
Dendritic cells (DCs) are believed to be essential in the initial activation of islet-specific T cells in PPLNs (27 Fig. 4B and C) . There were no differences among these DC subsets in cervical LNs (Online Appendix Fig. 4A and B) . Since DCs capture antigen in tissues and then migrate into draining lymph nodes to present their antigens to T cells, we asked whether the presence of M3 in the islets would alter the composition of DCs present in the islets. We isolated islets from NOD and NOD-M3 mice and stained single cell suspensions with different surface markers. As shown in Figure 4D -F, we observed a significant reduction in the relative number of CD11c + CD11b + cells in islets of NOD-M3 mice (22.9±3.4 % in NOD mice vs. 11.1±1.5 % in NOD-M3 mice; P =0.0054 Fig. 4E ), as well as in the absolute number of this DC subset (Fig. 4F) Appendix Fig. 4C ). To investigate whether this difference was driven solely by the expression of M3, we measured the number of CD11c + CD11b + DCs in islets of mice that are not prone to autoimmunity. To this end, we isolated islets from B6 and 6RIP-M3 mice (RIP-M3 mice (17) crossed over 10 times into the B6 background). We found that the expression of M3 in a nonautoimmune background does not alter the relative or the absolute numbers ( Fig. 5A and B) of any DC subset analyzed. Taken together, these results indicate that M3 expression by β cells in NOD mice decreases inflammation in the islets, impairs the migration of a subset of DCs into the islets and PPLNs, and reduces the proliferation of diabetogenic cells in the draining lymph nodes.
DISCUSSION
In this study we examined the role of the chemokine system in an experimental model of diabetes. We show that chemokine expression precedes development of diabetes and that islet-specific blockade of chemokine function reduces the local inflammation that results in a defective development and pancreatic accumulation of diabetogenic cells. These results thus, constitute formal demonstration that chemokines are critical determinants of autoimmune diabetes.
A pattern of multiple chemokine expression is found in the islets of NOD mice prior to disease. Our results confirm and expand results obtained by other groups (12; 22; 28) . Pre-diabetic NOD islets expressed inflammatory (CCL1, CCL3, CCL4, CCL22, CCL24, CXCL9 and CXCL10) as well as homeostatic chemokines (CCL21). The expression of all chemokines was closely associated, but not limited, to the inflammatory cells. For instance, CCL24 was expressed in vascular endothelial cells and CXCL9, previously reported in lining capillaries in the islets (22) , was also expressed by PNAd positive vessels within the islets. This finding is of interest since CXCL9 expression has been detected in high endothelial vessels of inflamed lymph nodes (29), but not in pancreatic islets. The combined expression of CXCL9 and CCL21 by endothelial cells may be important for recruitment of CXCR3 positive effector T cells, as well as for recruitment of dendritic cells and memory T cells expressing CCR7. Increased expression of CCL21 may also contribute to the development of segregated T and B cell aggregates reported within prediabetic NOD islets, and to the recruitment of CCR7 positive monocytes and DCs (12; 30) .
To date most attempts to interfere with the chemokine pathways in diabetes have relied on the use of neutralizing antibodies to chemokines or chemokine receptors. Neutralization of CXCL10, partially prevents autoimmune disease in the (RIP)-LCMV mouse model (31) and in NOD mice after cyclophosphamide administration (22) . CXCL10 DNA vaccination of NOD mice also partially prevents diabetes (32) . Neutralization of CCL22 with an antibody causes a significant reduction of CCR4-positive T cells within the pancreatic infiltrates and partially inhibits the development of diabetes in adoptive transfer model in NOD-SCID (14) . Furthermore, treatment of NOD mice with a neutralizing anti-CCR5 antibody reduces incidence of diabetes (33) . In all these studies, the individual treatments reduce inflammatory infiltrates, but do not completely block diabetes development, suggesting additional requirements.
To test the hypothesis that diabetes is caused by the combined activities of several chemokines we used M3, a chemokine binding protein encoded by the mouse herpesvirus 68 (MHV68) that binds several murine and human chemokines with high affinity (34; 35) . M3 interacts with the N-loop of chemokines and mimics elements of GPCR recognition to block interaction with cognate receptors by a competitive inhibition mechanism (36; 37). In vivo, M3 reduces mononuclear cellular responses after MHV68-induced meningitis in mice (38) . Systemic expression of M3 reduces intimal hyperplasia subsequent to femoral artery injury (39) and aortic allograft transplantation (40) . Finally, and perhaps more important in the context of these studies, expression of M3 in transgenic islets inhibits recruitment of leukocytes induced by islet-specific expression of CCL21 (17), CXCL13 and CCL2 (41) , and prevents insulitis and diabetes induced by multiple low doses of streptozotocin (18 of each subset (analysis was performed in alive (PI -), CD45 + cells; average ± SD of three independent experiments). Absolute number of DC subsets in isolated islets represents the absolute number of DCs per 100 islets.
